obesity drug news today glp-1 Drugs: 6 Things We've Learned About Their Effects How Supply and Demand for
Description
For patients where cardiovascular protection is a priority, semaglutide is the preferred GLP-1 medication
The meta-analysis further broke down how common nausea is for the five FDA-approved GLP-1 drug types, and another study looked at tirzepatides rate: Dulaglutide: 5-29% Exenatide: 5-59% Liraglutide: 10-48% Lixisenatide: 16-40% Semaglutide: 8-58% Tirzepatide: 20.43% Youll notice that these percentages vary quite a bit
E., Knudsen L
The global market size for GLP-1RAs was valued at USD 53.46 billion in 2024, with North America accounting for 77% of the total revenue share
Panagaki T, Gengler S, Hlscher C
